04 Jul 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines (TCM), China Botanic Pharmaceutical's, Siberian Ginseng Extract was recognized as safe medicine at the 8th session of the Selection Event, hosted by the Health Newspaper in China and supported by the Ministry of Health of China.
At the 8th session of the Selection event, a total of 30 medicines manufactured by 30 Chinese pharmaceutical companies were recognized as Safe Medicine by civilians. Since its debut in 2004, the Selection Event is well known in China's pharmaceutical industry. The selection procedure includes conducting surveys of Chinese consumers and their opinion of products offered by domestic pharmaceutical companies The Selection Event is designed to understand the needs of patients and gain valuable insights from the general population on the quality and remedial effect of different medications.
"We are honored that our Siberian Ginseng Extract product has been recognized as Safe Medicine by our domestic consumers along with 29 other medicines from well-known pharmaceutical companies. We believe this reflects on our commitment to deliver high-quality products which optimally meet our customer's needs," commented Mr Shaoming Li, chairman and chief executive officer of China Botanic. "We are encouraged by this recognition as we continue to make efforts to expand the scope and reach of Siberian Ginseng in China and internationally."